Safety and Efficacy Study of an Iontophoretic Patch Containing Lidocaine and Epinephrine for Venipuncture in Healthy Adult Volunteers

Inclusion Criteria: * Subjects may be of any race, either sex, and must be \>18 years of age * Healthy subjects as per medical screening * Subjects must have intact, healthy skin (no tattoos, surgical scars, skin infections, etc.) where the iontophoresis treatment will be performed * Subjects must be alert, oriented, mentally competent, and able to understand and comply with the requirements of the study * Subjects must have signed and dated a written informed consent * Female subjects of childbearing potential must have a negative pregnancy test result prior to the iontophoresis treatment Exclusion Criteria: * Subjects with a known allergy or sensitivity to lidocaine, epinephrine or other local anesthetics of the amide or ester type * Subjects with a know sensitivity to any components (e.g. adhesives) of the IDDSSubjects who have undergone venipuncture in the treatment area within the prior 2 weeks or longer if bruising or hematoma is apparent * Subjects who have taken an analgesic pain medication during the 24-hour period prior to the venipuncture in the posterior surface of the hand * Subjects with skin allergies or have skin diseases (e.g. psoriasis, eczema * Subjects with an open skin lesion at the treatment site * Subjects who are pregnant or breastfeeding * Subjects exposed to an investigational drug or device within the past 30 days or are involved concurrently in other treatment clinical trials * Subjects who participated in previous DTI/Transcu clinical studies related to this product * Subjects with known concurrent illness * Subjects with "current" known/admitted substance abuse (alcohol/drug) * Subjects with pacemakers and/or externally mounted electronic devices * Current or history of conditions that contraindicate use of iontophoretic treatment or venipuncture